INNOPHARMASCREEN
INNOPHARMASCREEN
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Incheon, Inch'on-jikhalsi, South Korea
Country:
South Korea
Status:
Active
Contact:
+82-(0)32-834-8321
Email Addresses:
[email protected]
Total Funding:
5.5 B KRW
Similar Organizations
Chem4pharma
Chem4pharma is a Drug Discovery company
ImmunoFrontier Inc.
ImmunoFrontier Inc. is a Japanese drug discovery venture company
PharmaDesign
PharmaDesign is a genomic drug discovery venture company.
Vitas Pharma
Vitas Pharma is a drug discovery company.
Investors List
Capstone Partners Co., Ltd.
Capstone Partners Co., Ltd. investment in Series A - Innopharmascreen
KDB Capital
KDB Capital investment in Series A - Innopharmascreen
Magna Investment
Magna Investment investment in Series A - Innopharmascreen
Aju IB Investment
Aju IB Investment investment in Series A - Innopharmascreen
Magna Investment
Magna Investment investment in Series A - Innopharmascreen
More informations about "Innopharmascreen"
Innopharmascreen Company Profile | Management and …
/ InnoPharmaScreen IPS CHIP - Based PPI / In silico Drug Design Platform / Anti-Cancer drug / Anti-Inflammation drug . Popular Searches. Innopharmascreen Inc. InnoPharmaScreen. …See details»
InnoPharmaScreen, Inc. - Drug pipelines, Patents, Clinical trials
100 Clinical Results associated with InnoPharmaScreen, Inc. Login to view more data. ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted …See details»
InnoPharmaScreen - PitchBook
InnoPharmaScreen is headquartered in Incheon, South Korea. What is the size of InnoPharmaScreen? InnoPharmaScreen has 3 total employees. What industry is …See details»
InnoPharmaScreen
메인 콘텐츠로 바로가기. pipe line. companySee details»
Innopharmascreen - Company Profile - Tracxn
Nov 27, 2024 InnoPharmaScreen develops therapeutics drugs for cancer and other diseases like Alzheimer's and inflammatory diseases. It offers its three propriety technology MOA …See details»
InnoPharmaScreen Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for InnoPharmaScreen Inc. of Incheon, Incheon. Get the latest business insights from Dun & …See details»
Innopharmascreen - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 10, 2020: ... Series A - …See details»
Innopharmascreen - Overview, News & Similar companies
View Innopharmascreen (www.innopharmascreen.com) location in New South Wales, Australia , revenue, industry and description. Find related and similar companies as well as employees …See details»
Aurora kinase A/B inhibitor program (InnoPharmaScreen)
Aurora kinase A/B inhibitor program (InnoPharmaScreen): a Serine/threonine-protein kinase Aurora inhibitors Drug, Initially developed by InnoPharmaScreen, Inc., Now, its global highest …See details»
InnoPharmaScreen - Products, Competitors, Financials, Employees ...
InnoPharmaScreen's proprietary technology includes a platform for in silico drug design aimed at producing anti-cancer and anti-inflammation drugs. It is based in Incheon, South Korea. …See details»
pipe line - InnoPharmaScreen
메인 콘텐츠로 바로가기. pipe line. companySee details»
IPS-06060 (MG degrader) - Drug Targets, Indications, Patents
IPS-06060 (MG degrader), Initially developed by InnoPharmaScreen, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active ...See details»
Innopharmascreen - Tech Stack, Apps, Patents & Trademarks
Organization. Innopharmascreen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. ... The …See details»
Innopharmascreen - Updates, News, Events, Signals & Triggers
Organization. Innopharmascreen . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity.See details»
IPS-07004 deriv. - Drug Targets, Indications, Patents - Synapse
Nov 30, 2024 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
InnoPharmaScreen Stock Price, Funding, Valuation, Revenue
See InnoPharmaScreen funding rounds, investors, investments, exits and more. Evaluate their financials based on InnoPharmaScreen's post-money valuation and revenue.See details»
Series A - Innopharmascreen - 2020-12-10 - Crunchbase
Dec 10, 2020 Organization Name . Innopharmascreen . Announced Date Dec 10, 2020; Funding Type ...See details»
Integrin alpha 5/beta 1 (InnoPharmaScreen) - Drug Targets, …
Literatures (Medical) associated with Integrin alpha 5/beta 1 (InnoPharmaScreen) 14 Mar 2022 · Angewandte Chemie International Edition A Chemical Biology Toolbox Targeting the …See details»
IPS-04003 - Drug Targets, Indications, Patents - Synapse
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»